Optometry practice loans for New Zealand ODOB-registered optometrists and dispensing opticians .

Practice ownership in NZ is not legally restricted to ODOB-registered persons in the way dental practice ownership is restricted to DCNZ-registered dentists. However, every practice with a clinical consult room must engage at least one Optometrists and Dispensing Opticians Board-registered optometrist as the practising clinician under the Health Practitioners Competence Assurance Act 2003. ODOB registers optometrists in general scope and in the therapeutic-prescribing scope (which permits prescribing of certain ocular pharmaceuticals after additional training and recognition), and dispensing opticians in their own scope of practice. ODOB publishes the registration framework and scope definitions in full at odob.health.nz.

A new single-consult-room optometry practice in NZ commonly runs $250,000 to $500,000 fully kitted and fitted out. Clinical equipment commonly accounts for $130,000 to $230,000 (auto-refractor and slit lamp $35K-$70K combined, OCT entry-tier $45K-$80K, fundus camera $22K-$45K, non-contact tonometer $8K-$18K, consult-room kit). Dispensary fitout commonly accounts for $90K-$220K covering cabinetry, frame display, consult-room build, and reception. Starter frame inventory and contact-lens trial sets add $50K-$150K. Practice-management software, signage, and first-quarter working capital add a further $20K-$50K.

Established NZ optometry practices commonly transact in the $450,000 to $2,200,000 range depending on consult-room count, recall-list size, location, and dispensary mix. A single-consult-room practice with 3,000-5,000 active patients commonly sits in the $450K-$1M band. A two-consult-room practice with 6,000-10,000 active patients commonly sits in the $1M-$2.2M band. Multi-room or specialist practices including therapeutic-scope and contact-lens-heavy practices can transact higher. Goodwill (recall list, brand, location, frame supplier accounts) commonly dominates the price, with equipment and dispensary fitout secondary. Practice-sale agents publish indicative multiples but every practice is priced on its own recall list, dispensary turn, and lease position.

Optical coherence tomography (OCT) uses near-infrared light to produce high-resolution cross-sectional images of the retina, optic nerve, and anterior segment, supporting clinical assessment of glaucoma, macular degeneration, diabetic retinopathy, and other conditions. OCT units commonly run $45,000 to $160,000 in NZ depending on capability: spectral-domain at the entry tier, swept-source at the higher tier, and OCT-A (angiography) for retinal vasculature imaging at the higher end. OCT is increasingly standard rather than aspirational equipment in NZ optometry, sitting alongside the slit lamp and fundus camera as core kit, and it is the most common standalone equipment-finance ticket once a practice has its core slit lamp and refraction kit established.

Frame inventory behaves more like specialist retail stock than clinical equipment because it turns through the dispensary on a quarterly to annual cadence, is exposed to fashion and seasonal cycles, and is commonly extended on supplier credit accounts. Lender treatment is typically a working-capital line of credit, a short-term loan over 2 to 4 years, or a supplier-extended trading account against the buying group, rather than a chattel mortgage. A typical practice carries $80,000 to $300,000 of frame inventory at any time. Inventory PPSR registration is occasionally used by lenders or major suppliers but is less common than for hard-asset chattel mortgages.

Indicative rates on optometry practice finance commonly sit in the 8% to 12% per annum band depending on structure, security, and borrower profile. Equipment chattel mortgage on slit lamps, OCT, fundus cameras, and edgers from established suppliers commonly sits at 8-10% for established practices. Acquisition term loans secured by goodwill and equipment commonly sit at 8-10% for established acquirers via the major-bank medical-finance teams. New-principal facilities commonly sit at 9-11% reflecting the limited trading-history profile. Working-capital lines for frame inventory commonly sit at 10-13%. Final rate is set by the lender after assessment.

A GST-registered NZ optometry practice can typically claim the GST component on equipment acquired under chattel mortgage as input tax in the next GST return after settlement, subject to apportionment for the mixed-supply position and to the accountant's confirmation. The mixed-supply position arises because eye-examination services supplied by an ODOB-registered optometrist are typically GST-exempt healthcare services under the GST Act 1985, while the dispensary side (frames, lenses, contact lenses) is typically a taxable supply at 15%. The apportionment determines the input-tax claim ratio on shared inputs including OCT (used in clinical examination) and dispensary-related inputs. The accountant is the right person to confirm the apportionment method on the specific business position.

ACC payments for accident-related ophthalmic treatment under the Accident Compensation Act 2001 form part of the NZ optometry practice revenue mix alongside private-pay consult and dispensary fees, Ministry of Health-funded vision screening, and (where the practice runs them) Southern Cross or NIB health-insurer-rebated services. ACC pays under a published schedule and at standard contribution rates published by ACC. Lender medical-finance teams commonly view a layered revenue mix as more stable than purely private-pay practices, though ACC does not commonly dominate revenue at a typical optometry practice. ACC payments are typically outside GST. The practice management system commonly tracks the ACC component separately for both clinical and accounting purposes.

Many NZ independent optometry practices affiliate with a buying group such as Eyepro, Independent Optometrists Group, or similar that aggregates frame and lens supply, negotiates supplier accounts, and in some cases provides shared marketing and clinical resources. Affiliation evidence is commonly part of a finance application file because it documents supplier accounts (including designer accounts that may be by approval rather than open), frame and lens supplier statements, and the trading relationships supporting the dispensary inventory build. Lender medical-finance teams commonly recognise buying-group affiliation as a stability indicator alongside the clinical revenue mix.

In-house edging means the practice runs a lens edger, polisher, and finishing kit ($35,000 to $80,000) plus a stock-lens buffer to glaze single-vision and stock-power lenses on the day of dispensing. Same-day glazing lifts dispensary turnaround dramatically and supports a more consultative dispensary experience. Outsourcing glazing to a wholesale lab (Hoya, Essilor, Rodenstock NZ) means the practice carries no edging capex but accepts lab turnaround of typically 3 to 10 working days for stock-power jobs and longer for complex prescriptions. Both models are common in NZ; the choice tracks practice volume, demographic mix, and the principal's preference for operational simplicity versus same-day capability.

Where optometry equipment is financed under chattel mortgage and the practice is sold, the equipment finance is typically settled out of sale proceeds at completion. The lender holds a security interest registered on the Personal Property Securities Register (PPSR) against each financed asset and is paid out before the equipment can be transferred clear-title to the acquirer. Where the acquirer is taking on the equipment finance directly, a lender consent and novation is required; this is more common where the lender already funds the acquirer's wider business. Practice-purchase agreements commonly include a settlement schedule that addresses equipment-finance payouts alongside the goodwill and dispensary inventory consideration.

Therapeutic-scope optometry practices, where the principal holds ODOB therapeutic-scope registration permitting prescribing of certain ocular pharmaceuticals, are funded by the same lender pool as general-scope practices: major-bank medical-finance teams, Heartland Bank, UDC Finance, and Speirs Finance. Therapeutic-scope status is documented in the lender file as part of ODOB registration evidence and commonly supports a slightly broader case mix that includes more in-practice management of glaucoma, anterior-segment infection, and similar conditions. The structure choice (chattel mortgage, term loan, working-capital line) does not commonly differ from the general-scope case; the main difference is the case-mix documentation supporting the trading data the lender reviews.

A standalone equipment chattel mortgage on a slit lamp, OCT, fundus camera, or edger commonly settles in 2 to 4 weeks from quote to drawdown via UDC Finance, Heartland Bank, or a similar specialist asset-finance lender. A new-principal facility blending equipment, fitout, and a starter frame inventory line commonly takes 4 to 8 weeks reflecting the lease deed, supplier quote pack, and ODOB documentation. An established practice acquisition with goodwill term loan, equipment chattel mortgage, dispensary working-capital line, and lease assignment commonly takes 6 to 12 weeks from heads of agreement to settlement, with the lease assignment, supplier-account novations, and vendor due diligence typically the longest steps.

A personal guarantee from the principal practising optometrist is commonly required across the NZ optometry finance pool, particularly on practice acquisitions, new-practice setups, and term loans secured by goodwill. Standalone equipment chattel mortgages secured against the asset itself sometimes proceed without a personal guarantee for established practices with multi-year trading and strong serviceability, though many lenders still take a guarantee as standard. Working-capital lines for frame inventory commonly include a personal guarantee. The accountant and the practice solicitor are commonly part of the conversation about guarantee structuring and any limited-recourse or capped-guarantee options the lender may offer.